跳转至内容
Merck
CN

EGFR transactivates RON to drive oncogenic crosstalk.

eLife (2021-11-26)
Carolina Franco Nitta, Ellen W Green, Elton D Jhamba, Justine M Keth, Iraís Ortiz-Caraveo, Rachel M Grattan, David J Schodt, Aubrey C Gibson, Ashwani Rajput, Keith A Lidke, Bridget S Wilson, Mara P Steinkamp, Diane S Lidke
摘要

Crosstalk between different receptor tyrosine kinases (RTKs) is thought to drive oncogenic signaling and allow therapeutic escape. EGFR and RON are two such RTKs from different subfamilies, which engage in crosstalk through unknown mechanisms. We combined high-resolution imaging with biochemical and mutational studies to ask how EGFR and RON communicate. EGF stimulation promotes EGFR-dependent phosphorylation of RON, but ligand stimulation of RON does not trigger EGFR phosphorylation - arguing that crosstalk is unidirectional. Nanoscale imaging reveals association of EGFR and RON in common plasma membrane microdomains. Two-color single particle tracking captured formation of complexes between RON and EGF-bound EGFR. Our results further show that RON is a substrate for EGFR kinase, and that transactivation of RON requires formation of a signaling competent EGFR dimer. These results support a role for direct EGFR/RON interactions in propagating crosstalk, such that EGF-stimulated EGFR phosphorylates RON to activate RON-directed signaling.

材料
产品编号
品牌
产品描述

Roche
高亲和力抗 HA-生物素 (3F10), from rat IgG1
Sigma-Aldrich
蛋白酶抑制剂混合物套装V,无EDTA, A cocktail of four protease inhibitors for the inhibition of serine, cysteine, but not metalloproteases.
Sigma-Aldrich
PD 153035, InSolution, ≥97%, potent and specific inhibitor of the tyrosine kinase activity of EGFR